Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma

Cancer Letters

Volumn 279, Issue 1, 2009, Pages 65-73

  Li, Dan juan ^a   Deng, Gui ^a,b   Xiao, Zhi qiang ^a   Yao, Hui xin ^a,b   Li, Cui ^a   Peng, Fang ^a   Li, Mao yu ^a   Zhang, Peng fei ^a   Chen, Yong heng ^c   Chen, Zhu chu ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

14 3 3 sigma; Lung squamous carcinoma; Lymph node metastasis related protein; Proteomics

Indexed keywords

STRATIFIN;

ADULT; AGED; ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LUNG CARCINOMA; LUNG SQUAMOUS CARCINOMA; LYMPH NODE METASTASIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

AGED; AMINO ACID SEQUENCE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; DATABASES, PROTEIN; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXONUCLEASES; HUMANS; IMMUNOHISTOCHEMISTRY; LASERS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICRODISSECTION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOMICS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 67349197265     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.028     Document Type: Article

References (26)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Steeg P.S. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer 3 (2003) 55-63
3. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Carnemolla B., Orecchia P., Zardi L., and Righetti P.G. Blue silver: a very sensitive colloidal coomassie G-250 staining for proteome analysis. Electrophoresis 25 (2004) 1327-1333
4. Hara A., and Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol. 108 (2004) 43-48
5. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2 (2002) 563-572
6. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell. Signal. 11 (1999) 545-554
7. Takahashi K., Sasaki T., Mammoto A., Takaishi K., Kameyama T., Tsukita S., and Takai Y. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272 (1997) 23371-23375
8. Jones M.B., Krutzsch H., Shu H., Zhao Y., Liotta L.A., Kohn E.C., and Petricoin III E.F. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2 (2002) 76-84
9. Jiang D., Ying W., Lu Y., Wan J., Zhai Y., Liu W., Zhu Y., Qiu Z., Qian X., and He F. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3 (2003) 724-737
10. Fan J., Ren H., Jia N., Fei E., Zhou T., Jiang P., Wu M., and Wang G. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J. Biol. Chem. 283 (2008) 4022-4030
11. Kim R.H., Peters M., Jang Y., Shi W., Pintilie M., Fletcher G.C., DeLuca C., Liepa J., Zhou L., Snow B., Binari R.C., Manoukian A.S., Bray M.R., Liu F.F., Tsao M.S., and Mak T.W. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7 (2005) 263-273
12. Kong J.P., Ding F., Zhou C.N., Wang X.Q., Miao X.P., Wu M., and Liu Z.H. Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. World J. Gastroenterol. 10 (2004) 1093-1097
13. Tolson J.P., Flad T., Gnau V., Dihazi H., Hennenlotter J., Beck A., Mueller G.A., Kuczyk M., and Mueller C.A. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics 6 (2006) 697-708
14. Hermani A., De Servi B., Medunjanin S., Tessier P.A., and Mayer D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 312 (2006) 184-197
15. Otsuki T., Yata K., Takata-Tomokuni A., Hyodoh F., Miura Y., Sakaguchi H., Hatayama T., Hatada S., Tsujioka T., Sato Y., Murakami H., Sadahira Y., and Sugihara T. Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. Brit. J. Haematol. 127 (2004) 292-298
16. Seliger B., Fedorushchenko A., Brenner W., Ackermann A., Atkins D., Hanash S., and Lichtenfels R. Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Clin. Cancer Res. 13 (2007) 27-37
17. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., and Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1 (1997) 3-11
18. Prasad G.L., Valverius E.M., McDuffie E., and Cooper H.L. Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 3 (1992) 507-513
19. Yang H.Y., Wen Y.Y., Lin Y.I., Pham L., Su C.H., Yang H., Chen J., and Lee M.H. Roles for negative cell regulator 14-3-3 sigma in control of MDM2 activities. Oncogene 26 (2007) 7355-7362
20. Lodygin D., Diebold J., and Hermeking H. Prostate cancer is characterized by epigenetic silencing of 14-3-3 sigma expression. Oncogene 23 (2004) 9034-9041
21. Ferguson A.T., Evron E., Umbricht C.B., Pandita T.K., Chan T.A., Hermeking H., Marks J.R., Lambers A.R., Futreal P.A., Stampfer M.R., and Sukumar S. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA 97 (2000) 6049-6054
22. Umbricht C.B., Evron E., Gabrielson E., Ferguson A., Marks J., and Sukumar S. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20 (2001) 3348-3353
23. Iwata N., Yamamoto H., Sasaki S., Itoh F., Suzuki H., Kikuchi T., Kaneto H., Iku S., Ozeki I., Karino Y., Satoh T., Toyota J., Satoh M., Endo T., and Imai K. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19 (2000) 5298-5302
24. Lodygin D., Yazdi A.S., Sander C.A., Herzinger T., and Hermeking H. Analysis of 14-3-3 sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 22 (2003) 5519-5524
25. Lodygin D., and Hermeking H. Epigenetic silencing of 14-3-3 sigma in cancer. Semin. Cancer Biol. 16 (2006) 214-224
26. Cheng A.L., Huang W.G., Chen Z.C., Peng F., Zhang P.F., Li M.Y., Li F., Li J.L., Li C., Yi H., Yi B., and Xiao Z.Q. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin. Cancer Res. 14 (2008) 435-445